ProCE Banner Activity

Analytical Treatment Interruptions: A Necessary Fact in HIV Cure Trials

Clinical Thought

Analytical treatment interruptions (ATIs) of antiretroviral therapy are needed in HIV cure-related trials to predict viral control after therapy is stopped. ATIs can cause anxiety for people living with HIV and their providers. Learn about the different ATI approaches, criteria for antiretroviral therapy restart, and strategies to reduce HIV transmission during ATI periods.

Released: December 21, 2023

Share

Faculty

Sharon R. Lewin

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor and Head, Department of Infectious Disease
The University of Melbourne
Consultant Physician
Royal Melbourne and Alfred Hospitals
Melbourne, Australia

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Sharon R. Lewin, AO, FRACP, PhD, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor and Head, Department of Infectious Disease
The University of Melbourne
Consultant Physician
Royal Melbourne and Alfred Hospitals
Melbourne, Australia

Sharon R. Lewin, AO, FRACP, PhD, FAA, FAHMS: consultant/advisor/speaker: AbbVie, Efsam, Gilead, Immunocore, Merck, Vaxxinity, ViiV; safety monitoring committee: Gilead; researcher: Gilead, Merck.